Dental
Wasatch Pediatrics, INC
Wasatch Pediatrics, INC was paid $5.81M by Medicaid between Jan 2018 and Dec 2024, across 105 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 37% of everything it billed.
33Billing provider infoWASATCH PEDIATRICS, INC
WEST JORDAN, UT 84088
WEST JORDAN, UT 84088
33aNPI1124102595assigned 10/24/2006
33bProvider typeOrthodontics and Dentofacial Orthopedic Dentist
28Total paid$5.81M
24GClaims193,730
24DCodes billed105
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Orthodontics and Dentofacial Orthopedic Dentist providers in Utah
Rank by total paid#1 of 27
Median peer was paid$68K
This provider vs. median85×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,121 | $426K | |
| 2019 | 9,706 | $390K | |
| 2020 | 9,166 | $303K | |
| 2021 | 22,913 | $985K | |
| 2022 | 25,432 | $1.17M | |
| 2023 | 56,112 | $1.16M | |
| 2024incomplete | 60,280 | $1.38M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 37% | 33,472 | 30,890 | $2.15M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 17,908 | 16,753 | $1.52M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 9,506 | 8,635 | $653K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.8% | 7,548 | 7,376 | $397K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.2% | 4,653 | 4,573 | $244K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.1% | 1,341 | 1,259 | $121K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.9% | 14,969 | 14,529 | $108K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 2,502 | 2,434 | $99K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.3% | 21,216 | 20,703 | $73K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 2,402 | 2,257 | $63K |
| 99460 | <1% | 719 | 694 | $48K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,513 | 1,461 | $38K |
93 more codes
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 625 | $35K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 645 | $32K |
| 99381 | <1% | 442 | $29K | |
| 90473 | <1% | 3,942 | $28K | |
| 90686 | <1% | 4,549 | $17K | |
| 99051 | <1% | 2,522 | $15K | |
| 96127 | <1% | 3,993 | $14K | |
| 99383 | <1% | 282 | $13K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,582 | $11K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 102 | $9K |
| 92551 | <1% | 5,012 | $8K | |
| 99463 | <1% | 93 | $8K | |
| 36416 | <1% | 3,977 | $6K | |
| 99382 | <1% | 141 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 57 | $5K |
| 90674 | <1% | 3,747 | $4K | |
| 83655 | <1% | 963 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 570 | $4K |
| 80061 | Lipid panel | <1% | 863 | $3K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,271 | $3K |
| 90480 | <1% | 448 | $3K | |
| 17110 | <1% | 49 | $3K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 37 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 85 | $3K |
| 81003 | <1% | 919 | $2K | |
| 87081 | <1% | 1,060 | $2K | |
| 0071A | <1% | 58 | $2K | |
| 99495 | <1% | 13 | $2K | |
| 90651 | <1% | 1,460 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 12 | $2K |
| 96161 | <1% | 2,071 | $1K | |
| 0072A | <1% | 41 | $1K | |
| 0154A | <1% | 39 | $1K | |
| 85018 | <1% | 1,273 | $1K | |
| 99462 | <1% | 35 | $1K | |
| 90670 | <1% | 1,940 | $1K | |
| 82248 | <1% | 261 | $781.98 | |
| 90680 | <1% | 3,619 | $768.92 | |
| 90619 | <1% | 1,088 | $763.85 | |
| 96380 | <1% | 100 | $745.30 | |
| 99177 | <1% | 4,980 | $661.87 | |
| 82247 | <1% | 262 | $649.28 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 12 | $605.57 |
| 0173A | <1% | 13 | $480.00 | |
| 82947 | <1% | 380 | $450.09 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 47 | $434.28 |
| 0124A | <1% | 12 | $404.80 | |
| 91307 | <1% | 164 | $360.18 | |
| 90716 | <1% | 1,044 | $348.69 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 160 | $336.90 |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 14 | $318.50 |
| 99384 | <1% | 13 | $302.67 | |
| 99417 | Prolong home eval add 15m | <1% | 13 | $282.92 |
| 90661 | <1% | 1,151 | $246.47 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 104 | $213.31 |
| 99188 | <1% | 30 | $196.57 | |
| 90620 | <1% | 327 | $191.76 | |
| 90715 | <1% | 736 | $190.44 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 192 | $174.81 |
| 91320 | <1% | 32 | $174.67 | |
| 90633 | <1% | 2,336 | $166.21 | |
| 87184 | <1% | 29 | $163.34 | |
| 91322 | <1% | 70 | $161.82 | |
| 99050 | <1% | 13 | $160.00 | |
| 90744 | <1% | 113 | $151.93 | |
| 91321 | <1% | 242 | $147.64 | |
| 90698 | <1% | 1,430 | $145.07 | |
| 87420 | <1% | 12 | $138.16 | |
| 90685 | <1% | 56 | $124.30 | |
| 90707 | <1% | 1,027 | $89.92 | |
| 96381 | <1% | 13 | $28.98 | |
| 90672 | <1% | 172 | $13.99 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | <1% | 100 | $6.00 |
| 90660 | <1% | 105 | $0.35 | |
| 91315 | <1% | 38 | $0.34 | |
| 90671 | <1% | 3,538 | $0.21 | |
| 91319 | <1% | 32 | $0.16 | |
| 91317 | <1% | 13 | $0.12 | |
| 91308 | <1% | 16 | $0.11 | |
| 91312 | <1% | 12 | $0.10 | |
| 90710 | <1% | 1,089 | $0.07 | |
| 90697 | <1% | 3,389 | $0.07 | |
| 90696 | <1% | 875 | $0.05 | |
| 90380 | 0% | 42 | $0.00 | |
| 90700 | 0% | 397 | $0.00 | |
| 90648 | 0% | 244 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 272 | $0.00 |
| 91300 | 0% | 16 | $0.00 | |
| 90734 | 0% | 29 | $0.00 | |
| 90677 | 0% | 468 | $0.00 | |
| 90688 | 0% | 21 | $0.00 | |
| 90381 | 0% | 88 | $0.00 | |
| 99174 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICE, ALYSHIA (PROVIDER RELATIONS)